Ocata Therapeutics Inc fka OCAT

[rumper]

Lasers, you're right again here about OCAT.

The IP that OCAT uses to assay the RPE cells,
the technology that is required to purify or
ensure that the RPE cells are actually differentiated,
completely and fully is the key to STEM cell
technology.

Without this technology, no one, absolutely no one,
moves forward with a STEM cell therapy.

AND OCAT OWNS IT !!!
(until the patents run out, anyway)

If the market makers don't understand this,
it's their loss. And it's not surprising because
these guys don't understand algebra, much less
calculus.

So, be patient. And carry on.

It's interesting, and always over looked by the
dunderheads, that the most recent OCAT presentation
specifically focused on the IP chain, and the patents.